Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 10, 2015, Pages 1760-1766

  Koutroubakis, Ioannis E ^a   Ramos Rivers, Claudia ^a   Regueiro, Miguel ^a   Koutroumpakis, Efstratios ^a   Click, Benjamin ^a   Schoen, Robert E ^a   Hashash, Jana G ^a   Schwartz, Marc ^a   Swoger, Jason ^a   Baidoo, Leonard ^a   Barrie, Arthur ^a   Dunn, Michael A ^a   Binion, David G ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

C Reactive Protein; Crohn's Disease; Erythrocyte Sedimentation Rate; Quality of Life; Ulcerative Colitis

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; REGISTER; ULCERATIVE COLITIS; VERY ELDERLY; WORLD HEALTH ORGANIZATION; COMPLICATION; MIDDLE AGED; PATHOLOGY; PENNSYLVANIA; SEVERITY OF ILLNESS INDEX; UNIVERSITY HOSPITAL; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PENNSYLVANIA; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84941742838     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.03.029     Document Type: Article

References (28)

1. Munkholm P., Langholz E., Davidsen M., et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995, 30:699-706.
2. Langholz E., Munkholm P., Davidsen M., et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994, 107:3-11.
3. Blonski W., Buchner A.M., Lichtenstein G.R. Clinical predictors of aggressive/disabling disease: ulcerative colitis and Crohn disease. Gastroenterol Clin North Am 2012, 41:443-462.
4. Levesque B.G., Sandborn W.J., Ruel J., et al. Converging goals of treatment for inflammatory bowel disease, from clinical trials and practice. Gastroenterology 2015, 148:37-51.
5. D'Haens G., Sandborn W.J., Feagan B.G., et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132:763-786.
6. Walsh A., Palmer R., Travis S. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Gastrointest Endosc Clin N Am 2014, 24:367-378.
7. Stein J., Dignass A.U. Management of iron deficiency anemia in inflammatory bowel disease - a practical approach. Ann Gastroenterol 2013, 26:104-113.
8. Oustamanolakis P., Koutroubakis I.E., Kouroumalis E.A. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis 2011, 5:381-391.
9. Kulnigg S., Gasche C. Systematic review: managing anemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24:1507-1523.
10. Gasche C., Berstad A., Befrits R., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007, 13:1545-1553.
11. Filmann N., Rey J., Schneeweiss S., et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis 2014, 20:936-945.
12. Rieder F., Paul G., Schnoy E., et al. Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior - a cohort study. PLoS One 2014, 9:e104706.
13. Wiskin A.E., Fleming B.J., Wootton S.A., et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohns Colitis 2012, 6:687-691.
14. Ramos-Rivers C., Regueiro M., Vargas E.J., et al. Association between telephone activity and features of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2014, 12:986-994.
15. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5-36.
16. Harvey R.F., Bradshaw J.M. A simple index of Crohn's disease activity. Lancet 1980, 1:514.
17. Kozarek R.A., Patterson D.J., Gelfand M.D., et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989, 110:353-356.
18. Jowett S.L., Seal C.J., Barton J.R., et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol 2001, 96:2921-2928.
19. Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO/UNICEF/UNU consultation 1998, World Health Organization, UNICEF, UNU, World Health Organization, Geneva, Switzerland.
20. Wilson A., Reyes E., Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):44S-49S.
21. Høivik M.L., Reinisch W., Cvancarova M., et al. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther 2014, 39:69-76.
22. Sjöberg D., Holmström T., Larsson M., et al. Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis 2014, 20:2266-2270.
23. Oustamanolakis P., Koutroubakis I.E., Messaritakis I., et al. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis 2011, 5:295-300.
24. Gibson P.R., Weston A.R., Shann A., et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol 2007, 22:1306-1312.
25. Gibson P.R., Vaizey C., Black C.M., et al. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J Crohn's Colitis 2014, 8:598-606.
26. Kalafateli M., Triantos C., Theocharis G., et al. Health-related quality of life in patients with inflammatory bowel disease: a single-center experience. Ann Gastroenterol 2013, 26:243-248.
27. Assa A., Hartman C., Weiss B., et al. Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease. J Crohns Colitis 2013, 7:369-376.
28. Koutroubakis I.E., Ramos-Rivers C., Regueiro M., et al. The influence of anti-TNF agents on hemoglobin levels of patients with inflammatory bowel disease. Inflamm Bowel Dis 2015, 21:1587-1593.